ALIVE is a mid-to-late stage HealthTech fund leveraging an exclusive ecosystem of strategic partners, to support and accelerate portfolio companies in their clinical and commercial expansion.
ALIVE’s Ecosystem Offers:
- Access to KOLs Clinical trials sites
- >3.5 Million patients & EMRs
- Clinical need validation Product validation Business model verification
- Exit strategy development Exposure to potential anchor clients Follow-on investments
Michel Habib
[email protected]
30 Habarzel St., Tel Aviv 6971042
+972-54-6381888
https://alivevc.com/
The Israeli HealthTech Opportunity
Israeli investors have been focusing on Seed and Early-stage investments for decades, increasing the gap between the progress of the HealthTech industry and the financial sector.
ALIVE bridges this widening gap by delivering value to its companies at every stage of the investment process, from product validation to patient bedside distribution.
Our current Portfolio is comprised of 5 promising companies:
Innovalve Bio, Magenta, Medisafe, Cynerio and Beyeonics.
ALIVE's Managing Partners bring a wealth of experience in the Healthcare and HealthTech industries:
Prof. Rafael Beyar, Managing General Partner, Former Director and CEO of Rambam Health Care Campus, Serial Entrepreneur
Michel Habib, Managing General Partner, Senior Biomed Venture Capitalist, Former CEO of Hadasit Bio Holdings
Prof. Ari Shamiss, Managing General Partner, Former CEO of Assuta Medical Centers & Director of Sheba General Hospital
Dudi Klein, Managing Partner, Former Head of Ventures and Innovation, Assuta Medical Centers, Entrepreneur
Our Investment Focus:
Surgical Robotics, Implanted Devices, Minimal Invasive Drug Delivery
Early Diagnostics, Imaging Sensors, Bioinformatics, Personalized Medicine
Telemedicine, Artificial Intelligence, Remote Patient Management, Healthcare IT, Cyber Security
Fund Terms and Metrics
Fund Size - USD150M target, Dec 2021
Initial Closing - USD50M, July 2020
Scope - Lead investor in USD15-40M syndicated rounds
Board - Active Board Membership
Portfolio - 12-15 Companies